QuickFISH is a rapid molecular diagnostic platform, developed by AdvanDx, that is now available exclusively in the UK from Alpha Laboratories. It provides 20-minute species identification of bacteria directly from positive blood cultures. This enables clinicians to prescribe the correct antimicrobial therapy for patients with bloodstream infections much earlier, ensuring better patient outcome, reduced hospital stay and lower medical costs. These assays are based on PNA probe technology and fluorescence in situ hybridisation (FISH).
[email protected]
